1 Table of Contents
1.1 List of Tables
List of Figures

2 Executive Summary
2.1 Otitis Media- Disease Overview
2.2 Otitis Media- Pipeline Snapshot
2.3 Otitis Media- Pipeline Drugs by Phase
2.4 Otitis Media- Pipeline Drugs by Company
2.5 Otitis Media- Pipeline Drugs by Mechanism of Action

3 Company wise Pipeline Analysis
3.1 Lee's Pharmaceutical Holdings Ltd Otitis Media Drug Pipeline, H2- 2019
3.2 Madam Therapeutics BV Otitis Media Drug Pipeline, H2- 2019
3.3 MerLion Pharmaceuticals Pte Ltd Otitis Media Drug Pipeline, H2- 2019
3.4 Novus Therapeutics Inc Otitis Media Drug Pipeline, H2- 2019
3.5 Olymvax Biopharmaceuticals Inc Otitis Media Drug Pipeline, H2- 2019
3.6 ProclaRx LLC Otitis Media Drug Pipeline, H2- 2019
3.7 Yuhan Corp Otitis Media Drug Pipeline, H2- 2019

4 Phase 1 Pipeline Drug Details
4.1 Otitis Media- Phase 1 Drug Details
4.2 Otitis Media- Phase 1 Drug Overview
4.3 Otitis Media- Phase 1 Mechanism of Action
4.4 Current Status
4.5 Trial Details

5 Phase 2 Pipeline Drug Details
5.1 Otitis Media- Phase 2 Drug Details
5.2 Otitis Media- Phase 2 Drug Overview
5.3 Otitis Media- Phase 2 Mechanism of Action
5.4 Current Status
5.5 Trial Details

6 Phase 3 Pipeline Drug Details
6.1 Otitis Media- Phase 3 Drug Details
6.2 Otitis Media- Phase 3 Drug Overview
6.3 Otitis Media- Phase 3 Drug Mechanism of Action
6.4 Current Status
6.5 Trial Details

7 Pre-clinical Phase Pipeline Drug Details
7.1 Otitis Media- Pre-clinical Phase Drug Details
7.2 Otitis Media- Pre-clinical Phase Drug Overview
7.3 Otitis Media- Pre-clinical Phase Drug Mechanism of Action
7.4 Current Status
7.5 Trial Details

8 Recent News and Developments

9 Appendix
9.1 About VPAResearch
9.2 Sources and Research Methodology

Companies mentioned
Lee's Pharmaceutical Holdings Ltd, Madam Therapeutics BV, MerLion Pharmaceuticals Pte Ltd, Novus Therapeutics Inc, Olymvax Biopharmaceuticals Inc, ProclaRx LLC, Yuhan Corp